AMARIN CORP PLC\UK
AMRN$335M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaDUBLIN 2
Drugs in Pipeline
4
Phase 3 Programs
4
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
AMRN News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
Drug Pipeline
Ethyl-EPA (Miraxion™)
Huntington Disease
AMR101 (ethyl icosapentate) - 4 g/day
Hypertriglyceridemia
AMR101 (ethyl icosapentate) - 2 g/day
Hypertriglyceridemia
AMR101
Cardiovascular Diseases
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Ethyl-EPA (Miraxion™) | Phase 3 | Huntington Disease | - | - |
AMR101 (ethyl icosapentate) - 4 g/day | Phase 3 | Hypertriglyceridemia | - | - |
AMR101 (ethyl icosapentate) - 2 g/day | Phase 3 | Hypertriglyceridemia | - | - |
AMR101 | Phase 3 | Cardiovascular Diseases | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply